Palvella Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.14 M | $173.51 M | -1.57% | 7.91% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 960.62 K | $146.80 M | 49.95% | 6.69% |
| BLACKROCK, INC. | 08/07/2026 | 918.36 K | $140.34 M | 33.71% | 6.40% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 882.40 K | $134.85 M | 0.00% | 6.15% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2026 | 771.90 K | $117.96 M | -21.30% | 5.38% |
| BVF INC/IL | 08/14/2026 | 672.79 K | $102.82 M | -29.99% | 4.69% |
| STATE STREET CORP | 08/07/2026 | 653.17 K | $99.82 M | 42.30% | 4.55% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 638.87 K | $97.63 M | 58.70% | 4.45% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 513.79 K | $78.52 M | 7.65% | 3.58% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 08/14/2026 | 478.83 K | $73.18 M | 28.02% | 3.34% |
| FEDERATED HERMES, INC. | 08/12/2026 | 433.02 K | $66.17 M | 0.00% | 3.02% |
| WOODLINE PARTNERS LP | 08/14/2026 | 317.52 K | $48.52 M | 0.00% | 2.21% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 292.36 K | $44.68 M | 117.21% | 2.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 276.16 K | $42.21 M | 34.32% | 1.92% |
| SIREN, L.L.C. | 08/13/2026 | 257.49 K | $39.35 M | 0.00% | 1.79% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/14/2026 | 256.18 K | $39.15 M | 31.36% | 1.78% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 253.17 K | $31.56 M | -3.68% | 1.76% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 231.48 K | $35.38 M | -0.76% | 1.61% |
| EMERALD ADVISERS, LLC | 08/05/2026 | 229.49 K | $35.07 M | 42.10% | 1.60% |
| FMR LLC | 08/13/2026 | 214.84 K | $32.83 M | -0.45% | 1.50% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 204.03 K | $31.18 M | -1.15% | 1.42% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 201.51 K | $30.80 M | 3.78% | 1.40% |
| MORGAN STANLEY | 08/13/2026 | 181.43 K | $27.73 M | 41.76% | 1.26% |
| FIRST TURN MANAGEMENT, LLC | 08/14/2026 | 156.45 K | $23.91 M | 5.64% | 1.09% |
| BELLEVUE GROUP AG | 08/14/2026 | 155.00 K | $23.69 M | 100.00% | 1.08% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 140.00 K | $21.39 M | 108.64% | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 08/05/2026 | 129.85 K | $19.84 M | 22.71% | 0.90% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 128.96 K | $19.71 M | 41.94% | 0.90% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 120.60 K | $18.43 M | -14.83% | 0.84% |
| ABRDN PLC | 07/31/2026 | 120.24 K | $18.37 M | 48.29% | 0.84% |
| NORTHERN TRUST CORP | 08/13/2026 | 97.19 K | $14.85 M | 50.99% | 0.68% |
| NEXTBIO CAPITAL MANAGEMENT LP | 08/14/2026 | 89.91 K | $13.74 M | 8.74% | 0.63% |
| CLIO ASSET MANAGEMENT LLC | 07/23/2026 | 86.34 K | $13.19 M | -4.86% | 0.60% |
| NEUBERGER BERMAN GROUP LLC | 08/13/2026 | 83.11 K | $12.70 M | 69.25% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 76.60 K | $11.71 M | 135.69% | 0.53% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 74.00 K | $11.31 M | 14.22% | 0.52% |
| UBS GROUP AG | 08/13/2026 | 72.53 K | $11.08 M | -30.62% | 0.51% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 70.00 K | $10.70 M | 0.00% | 0.49% |
| AWM INVESTMENT COMPANY, INC. | 08/14/2026 | 69.42 K | $10.61 M | 0.00% | 0.48% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 67.47 K | $10.31 M | -3.48% | 0.47% |
| SEVEN GRAND MANAGERS, LLC | 08/14/2026 | 60.00 K | $9.17 M | 0.00% | 0.42% |
| CLEARBRIDGE INVESTMENTS, LLC | 08/13/2026 | 59.34 K | $9.07 M | -0.12% | 0.41% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 54.55 K | $8.34 M | 43.67% | 0.38% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 53.27 K | $8.14 M | 196.44% | 0.37% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 52.21 K | $7.98 M | -44.25% | 0.36% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 51.66 K | $7.89 M | 31.71% | 0.36% |
| HSBC HOLDINGS PLC | 08/14/2026 | 50.00 K | $7.64 M | 100.00% | 0.35% |
| NICHOLAS INVESTMENT PARTNERS, LP | 08/14/2026 | 49.72 K | $7.60 M | 80.12% | 0.35% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 44.54 K | $6.81 M | -53.96% | 0.31% |
| LISANTI CAPITAL GROWTH, LLC | 08/10/2026 | 42.98 K | $6.57 M | 3.69% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Palvella Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 228 institutional investors and hedge funds held shares of Palvella Therapeutics Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 1.14 M
JENNISON ASSOCIATES LLC: 960,619
BlackRock, Inc.: 918,357
Frazier Life Sciences Management, L.P.: 882,400
First Light Asset Management, LLC: 771,901
BVF INC/IL: 672,789
98.39% of Palvella Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.71 M shares in the last 24 months. This purchase volume represents approximately $2.01 B in transactions.